{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-113210","form_type":"8-K","ticker":"LONA","cik":"0001620463","company_name":"LeonaBio, Inc.","filed_at":"2024-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.010909+00:00","generated_at":"2026-05-30T19:15:48.209124+00:00","sec_items":["9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Athira Pharma terminates CFO/CBO and COO/CDO; grants retention equity to CEO and VP Finance","bullets":["Andrew Gengos (CFO/CBO) and Rachel Lenington (COO/CDO) terminated Oct 1, 2024; severance payments of $363,750 and $375,000 respectively.","Lenington to provide consulting through Dec 31, 2024 at $41,666.67/month; equity vests during term.","CEO Mark Litton receives 325k RSUs + 325k options (strike $0.4257); VP Finance Renninger gets 37,077 RSUs + 37,077 options (strike $0.4499).","Retention awards vest 1/3 each on Dec 31, 2024, Jun 30, 2025, and Dec 31, 2025, subject to continued service.","2024 corporate goal achievement percentage automatically increased by 25 percentage points for certain executives."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-113210","json":"https://secwatch.observer/filing/0000950170-24-113210.json","markdown":"https://secwatch.observer/filing/0000950170-24-113210.md","text":"https://secwatch.observer/filing/0000950170-24-113210.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1620463/000095017024113210/0000950170-24-113210-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1620463/000095017024113210/atha-20241001.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T19:15:48.209124+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}